Laurus Labs Ltd (BOM:540222)

Q3 2025 Laurus Labs Ltd Earnings Call Transcript

Jan 24, 2025 / 11:30 AM GMT

Release Date Price: ₹601.25 (+2.79%)

Transcript

Key Points

Positve

Laurus Labs Ltd (BOM:540222) reported strong growth in Q3 2025, with revenue increasing by 18% year-on-year, driven by robust demand in the CDMO business.
The company maintained healthy gross margins above 50% for several quarters, with EBITDA margins improving to 21.1% due to better operating leverage.
Laurus Labs Ltd (BOM:540222) achieved the highest quarterly sales for the CDMO division in the last eight quarters, reflecting a 33% growth on a nine-month basis.
The company is expanding its R&D capabilities, including a new small molecule R&D center and a large-scale fermentation capacity, expected to be ready by the end of 2026.
Laurus Labs Ltd (BOM:540222) has a strong pipeline with over 90 active projects, including collaborations with big pharma partners, indicating potential for future growth.

Negative

The ARV API business saw a decline in revenues by 7% due to lower volume uptake, impacting overall performance.
Despite improvements, the company's profit after tax for Q3 was relatively low at 22 crores, with a ROSI of 6.8% due to continued CapEx investments.
The company faces challenges in capacity utilization, with some assets still ramping up, affecting operational efficiency.
Laurus Labs Ltd (BOM:540222) has not provided specific guidance on the number of new product commercializations, creating uncertainty about future revenue streams.
The company is heavily investing in CapEx, with a net debt of 2,766 crores, which could pose financial risks if expected growth does not materialize.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

LAUL.NS - Laurus Labs Ltd
Q3 2025 Laurus Labs Ltd Earnings Call
Jan 24, 2025 / 11:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day. And welcome to Norris Lab Limited Q3 F I 25 earnings conference call hosted by Dam Capital Advisors Limited.

As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call? Please signal an operator by pressing the star then zero on your Touchstone phone.

I now hand the conference over to Mr Nitin Agarwal from Dam Capital Advisors Limited. Thank you and over to you, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
----------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.